Senior Bioprocess Scientist I
Immunology · China · 2025-07-08
Framework Evaluation
3 of 3 criteria metThe petitioner's research on HBV mutations and CD1 T-cell immunotherapy is heavily cited and adopted in clinical applications.
The petitioner authored 19 peer-reviewed articles in top-ranked journals such as PNAS and Cell Reports.
The petitioner completed at least 89 verified reviews for leading journals including Frontiers in Immunology.
Why This Petition Was Approved
Request for Evidence (RFE)
Successfully AddressedThe RFE challenged the evidence of sustained acclaim and international recognition. The firm responded with expanded expert testimonials and robust documentation of the petitioner's influence.
Evidence
- Senior Bioprocess Scientist I at a distinguished organization
- Over 600 citations in the field of immunology
- 19 peer-reviewed publications in high-impact journals including Journal of Clinical Investigation, PNAS, and Cell Reports
- Completed 89 verified peer reviews for journals such as Frontiers in Immunology and Scientific Reports
- Editorial board membership for scientific journals
- Recipient of research funding from the NIH and the German Research Foundation
Similar Cases
Scientist
Biotechnology · China
Research Scientist
Biotechnology · Singapore
Postdoctoral Researcher
Biotechnology · India
Robotics Engineer
Robotics · China
Frequently Asked Questions
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-07-08.
Browse all casesAt a Glance
O-1 Case Data
Scraped Case Data
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist